HK1216298A1 - 用於減少夜尿的去氨加壓素 - Google Patents

用於減少夜尿的去氨加壓素

Info

Publication number
HK1216298A1
HK1216298A1 HK16104260.7A HK16104260A HK1216298A1 HK 1216298 A1 HK1216298 A1 HK 1216298A1 HK 16104260 A HK16104260 A HK 16104260A HK 1216298 A1 HK1216298 A1 HK 1216298A1
Authority
HK
Hong Kong
Prior art keywords
desmopressin
nocturnal voids
reducing nocturnal
reducing
voids
Prior art date
Application number
HK16104260.7A
Other languages
English (en)
Inventor
Jens Peter Norgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1216298A1 publication Critical patent/HK1216298A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
HK16104260.7A 2010-03-25 2013-05-23 用於減少夜尿的去氨加壓素 HK1216298A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/732,161 US20100286045A1 (en) 2008-05-21 2010-03-25 Methods comprising desmopressin

Publications (1)

Publication Number Publication Date
HK1216298A1 true HK1216298A1 (zh) 2016-11-04

Family

ID=44365354

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16104260.7A HK1216298A1 (zh) 2010-03-25 2013-05-23 用於減少夜尿的去氨加壓素
HK13106106.3A HK1179156A1 (zh) 2010-03-25 2013-05-23 用於減少夜間排尿的去氨加壓素

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13106106.3A HK1179156A1 (zh) 2010-03-25 2013-05-23 用於減少夜間排尿的去氨加壓素

Country Status (17)

Country Link
US (3) US20100286045A1 (zh)
EP (3) EP3449908A1 (zh)
JP (3) JP6253977B2 (zh)
CN (4) CN102821776A (zh)
CA (1) CA2793502A1 (zh)
DK (2) DK3006036T3 (zh)
ES (2) ES2559446T3 (zh)
HK (2) HK1216298A1 (zh)
HR (1) HRP20190104T1 (zh)
HU (1) HUE027417T2 (zh)
LT (1) LT3006036T (zh)
PL (2) PL3006036T3 (zh)
PT (2) PT3006036T (zh)
RS (1) RS58224B1 (zh)
SI (1) SI3006036T1 (zh)
TR (1) TR201900240T4 (zh)
WO (1) WO2012001469A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US20160098530A1 (en) * 2014-10-07 2016-04-07 David A. DILL Devices and methods for managing risk profiles
KR20210078500A (ko) 2018-10-17 2021-06-28 닛뽕 케미파 가부시키가이샤 야간 다뇨의 치료 또는 예방제
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
ATE24964T1 (de) 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
TW279133B (zh) 1990-12-13 1996-06-21 Elan Med Tech
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
ES2153362T3 (es) 1991-08-26 2001-03-01 Abbott Lab Composiciones y procedimientos de administracion sublingual o bucal de agentes terapeuticos.
NZ246091A (en) 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
WO1995001368A1 (en) 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
HU221617B1 (hu) 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
CA2176927C (en) 1993-11-17 2010-03-23 Seang H. Yiv Transparent liquid for encapsulated drug delivery
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
FR2720003B1 (fr) 1994-05-23 1998-06-26 Samsung Electro Mech Dispositif servant à inciser la peau pour une médication transcutanée.
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
AU3399197A (en) 1996-06-18 1998-01-07 Alza Corporation Device for enhancing transdermal agent delivery or sampling
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
ATE283708T1 (de) 1999-02-15 2004-12-15 Sumitomo Pharma Im mundraum schnellzerfallende tabletten
US6314317B1 (en) 1999-02-18 2001-11-06 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
AU7830000A (en) 1999-09-20 2001-04-24 Ethentica, Inc. Server-side implementation of a cryptographic system
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
WO2001051109A1 (en) 2000-01-07 2001-07-19 Biovalve Technologies, Inc. Injection device
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
MXPA03003815A (es) 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
EP1339442A4 (en) 2000-11-30 2006-12-27 Biovalve Technologies Inc INJECTION SYSTEMS
CA2430590C (en) 2000-11-30 2012-08-14 Biovalve Technologies, Inc. Fluid delivery and measurement systems and methods
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002050584A2 (en) 2000-12-21 2002-06-27 Biovalve Technologies, Inc. Microneedle array systems
CA2440884C (en) 2001-03-16 2012-05-22 Alza Corporation Transdermal patch for administering fentanyl
EP1381370B1 (en) 2001-04-12 2007-03-07 Wyeth N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
CA2443870A1 (en) 2001-04-12 2002-10-24 Wyeth Cyclohexylphenyl vasopressin agonists
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
KR100874952B1 (ko) 2001-09-13 2008-12-19 깃세이 야쿠힌 고교 가부시키가이샤 히드록시노르에페드린 유도체 염산염의 결정
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
KR100632882B1 (ko) 2001-11-16 2006-10-13 아스텔라스세이야쿠 가부시키가이샤 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5ｈ-1-벤즈아제핀 유도체 또는 그 염
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003094886A2 (en) 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
CA2516547A1 (en) 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
JP4016986B2 (ja) 2002-10-09 2007-12-05 東レ株式会社 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
SI1619185T1 (sl) 2003-04-28 2011-09-30 Astellas Pharma Inc 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DK1638468T3 (da) 2003-06-30 2007-12-17 Alza Corp Fremgangsmåde til coating af hudpiercingmikrofremspring
US7022340B2 (en) 2003-07-25 2006-04-04 Ferring B.V. Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
US20050089554A1 (en) 2003-10-24 2005-04-28 Cormier Michel J. Apparatus and method for enhancing transdermal drug delivery
WO2005042054A2 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
EP1680154B1 (en) 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
EP2322195A2 (en) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (es) 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
FR2862230B1 (fr) 2003-11-17 2005-12-16 Rossignol Sa Fixation de surf
SI1550439T1 (sl) 2003-12-29 2006-08-31 Ferring Bv Postopek za pripravo trdne dozirne oblike dezmopresina
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2552754A1 (en) 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
WO2006029411A2 (en) 2004-09-09 2006-03-16 Yeda Research And Development Co. Ltd. Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US20080009801A1 (en) 2004-12-02 2008-01-10 Nickel Janice H Method for dispensing material into a drug delivery device
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
WO2006116151A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
CN101203216A (zh) 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
CA2605587A1 (en) 2005-04-22 2006-11-02 Wyeth Chromane and chromene derivatives and uses thereof
BRPI0610046A2 (pt) 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
CN101203217A (zh) 2005-04-24 2008-06-18 惠氏公司 调节膀胱功能的方法
CA2612005C (en) 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
WO2007002523A2 (en) 2005-06-24 2007-01-04 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007021970A2 (en) 2005-08-15 2007-02-22 Praecis Pharmaceuticals, Inc. Stable pharmaceutical formulations and methods of use thereof
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
WO2007098945A2 (en) 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
US8101114B2 (en) 2006-05-01 2012-01-24 Georgia Tech Research Corporation Particle based molding
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
PT3085381T (pt) 2008-05-21 2018-05-18 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
JP5151774B2 (ja) 2008-07-29 2013-02-27 株式会社リコー クリーニング装置、プロセスユニット及び画像形成装置
US20150306170A1 (en) 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release

Also Published As

Publication number Publication date
JP6545778B2 (ja) 2019-07-17
EP2550007A1 (en) 2013-01-30
EP3449908A1 (en) 2019-03-06
ES2559446T3 (es) 2016-02-12
RS58224B1 (sr) 2019-03-29
CN110898207A (zh) 2020-03-24
PT2550007E (pt) 2016-02-15
US20140113863A1 (en) 2014-04-24
TR201900240T4 (tr) 2019-02-21
SI3006036T1 (sl) 2019-02-28
HK1179156A1 (zh) 2013-09-27
US20190134146A1 (en) 2019-05-09
CN107252474A (zh) 2017-10-17
CN106924716A (zh) 2017-07-07
EP2550007B1 (en) 2015-10-21
HRP20190104T1 (hr) 2019-03-08
JP2016153420A (ja) 2016-08-25
US10137167B2 (en) 2018-11-27
US11020448B2 (en) 2021-06-01
JP6297616B2 (ja) 2018-03-20
CA2793502A1 (en) 2012-01-05
PT3006036T (pt) 2019-01-17
WO2012001469A1 (en) 2012-01-05
HUE027417T2 (en) 2016-10-28
DK2550007T3 (en) 2016-01-18
CN102821776A (zh) 2012-12-12
EP3006036A1 (en) 2016-04-13
EP3006036B1 (en) 2018-10-31
DK3006036T3 (en) 2019-02-25
JP2018076344A (ja) 2018-05-17
PL2550007T3 (pl) 2016-04-29
LT3006036T (lt) 2019-02-25
PL3006036T3 (pl) 2019-04-30
JP2013523628A (ja) 2013-06-17
US20100286045A1 (en) 2010-11-11
ES2708973T3 (es) 2019-04-12
JP6253977B2 (ja) 2017-12-27

Similar Documents

Publication Publication Date Title
EP2565069A4 (en) INTRODUCTION STRUCTURE OF COOLING AIR CURRENT
GB201103504D0 (en) Electric machine - over-moulding construction
GB201010196D0 (en) Methods
HK1171476A1 (en) Apparatuses
EP2621275A4 (en) ARYL-SUBSTITUTED IMIDAZOLE
GB2485334B (en) Structure
HRP20190104T1 (hr) Desmopresin za smanjenje noćnih buđenja
GB201015324D0 (en) Secure association
HK1178622A1 (zh) 可恢復的方法
GB201117661D0 (en) Early entry
GB201007944D0 (en) Methods
EP2615328A4 (en) REDUCTION DEVICE
EP2591985A4 (en) PANEL ASSEMBLY STRUCTURE
GB201002409D0 (en) Methods
GB201301684D0 (en) Early entry
EP2659388A4 (en) PARTIAL CACHES STORAGE OF OBJECTS
GB201016346D0 (en) Connection means
GB2483908B (en) Nacelle
GB201018364D0 (en) Cable keep
GB201015567D0 (en) Methods
GB201011367D0 (en) Methods
GB201011010D0 (en) Methods
GB201118411D0 (en) Not available
GB2483726B (en) Cable save
PL2580068T3 (pl) Struktura zabezpieczona